Australia’s #1 small cap stock newsletter.

Daily write ups on small cap stocks we are invested in

Our Investments

Each year we review over 400 opportunities, on average we make just 10 new Investments.

A Portfolio Company that we have an active contract with to share our commentary.
A Portfolio Company that has not delivered on our Investment Memo objectives in a reasonable timeframe, or a key risk has materialised. We hold a position in the hope that it may eventually deliver a surprise outcome or acquire a new project OR we may look to exit these positions to free up capital for new Investments.
A Portfolio Company that we hold a position in and are interested in the company.
A Portfolio Company that we no longer hold a position in.
A company that has been added to one of our Portfolios (Next Investors, Catalyst Hunter, Next Biotech, Wise-Owl, Emerge).
A Portfolio Company that has exceeded our expectations and either delivered on our "Big Bet" OR delivered an outsized return during our minimum hold period. The company will either continue as a Current Investment OR we may eventually exit the position.

The past performance is not and should not be taken as an indication of future performance. Caution should be exercised in assessing past performance. This product, like all other financial products, is subject to market forces and unpredictable events that may adversely affect future performance.

Our Portfolios

Discover our diverse portfolios across a number of different sectors.

Opportunities Portfolio

Special opportunities across a broad range of sectors at an early stage of growth with strong management. Seeking 1,000% plus returns across a medium to long term hold

Time Frame 3 to 5 years

Early Stage Portfolio

Short term positions in small early stage ASX companies with high potential, near term price catalysts. Focus on resource exploration, early stage tech and biotech

Time Frame 2 to 3 years

Growth Portfolio

Longer term positions in a variety of sectors. Seeking strong management where traction has been established and company has entered into a growth phase.

Time Frame 4 to 7 years

Biotech Portfolio

Next Biotech is following on from one of Australia’s most successful biotech and life sciences fund managers to select and invest in early to mid-stage ASX listed biotechs.

Time Frame 3 to 5 years

Emerge Portfolio

Positions in companies with real assets that had been trading at low valuations due to solvable factors in the medium term, and have been recently recapitalised.

Time Frame 3 to 5 years

FAQs

Answers to frequently asked questions.

Why is the newsletter free to subscribe?

Our business model is driven by generating long term returns from our Investment Portfolio.

We share our views via our newsletter which is free to subscribe to.

In order to keep our newsletter free, we offer an exclusive service to the companies we are Invested in, where we will share our commentary, analysis and investment journey in the company with our subscribers.

We may charge the companies a fee for this service, which is used to cover our business operating costs including of our analysts and writers.

This is an exclusive service that we only offer to companies that we are Invested in that have passed our rigorous due diligence process.

What do I get as a Next Investors subscriber?

As a subscriber you will be the first to know when we announce a new Investment, and you will get regular commentary about the Current Investments in our Portfolio.

Expect to see a maximum of one email per day.

Monday to Friday emails will have a comprehensive deep dive about a particular stock in our Portfolio - one that likely has some big news or big news coming that we think would be of interest to our subscribers.

On Saturdays, we send our commentary on the markets and the macro environment that affects the companies we invest in.

On Sundays we send a summary of all the content we published during the week and news or other content that we have been following.

It’s all free to subscribe to, and you can unsubscribe at any time.

Who is behind Next Investors?

Damian Hajda here, original founder and director of Next Investors.

I have been investing in ASX small cap stocks since I was 17, made money, lost money and learned many lessons after 20+ years in the game.

Myself and my business partner Jason Price (also a very experienced ASX investor) make the final investment decision on each company and we spend most of our time analysing new investments or writing our commentary across our portfolio companies.

Next Investors is based in Melbourne, Australia. We are a small team of six and you can find our bios here.

Can I recommend a stock for the newsletter?

Yes, you can.

We look at every stock suggestion and recommendation that is sent in by our readers.

These suggestions move to our due diligence queue and are reviewed by one of our analysts.

Due to the amount of stock suggestions and recommendations that we receive every week we cannot provide our opinion on each one directly - we are still a small team, and we don't offer personal investment advice.

For stock recommendations fill out the form on our Contact Us Page.